Hello Darc. Couple comments. One the market does not have more fundi knowledge if you yourself dig. I can assure you in every meeting I have had at the HF I have had an angle on a name they have not. You would be surprised how much copying is being done at high levels of finance. Stocks are not cheap for a good reason they are usually cheap because of interest rates and bond levels. Those are adjustable inputs and have nothing really to do with earnings. As a chart reader: One of the most basic things to learn is when a name is washed out. The easiest money is always the first money... then people will clue in and the buys meet the sells. I think of GE as a good example. Buying out of favor names will usually find you in front eventually if you have done your research. As well there is the bounce effect when a stk becomes oversold. Why do those bounces work so well? Well the willing sellers have already sold... the ratio then at this price is tilted more towards new, different money coming in. Every stock has it's own story and it's own way of moving: but in general if you keep a list in your head of quality names and buy them on days of distress earnings misses etc. You will be getting yourself excellent entry points. They call this Behavioral Value<-------- and I have made a point of being very good at isolating these type of names.
PDYN Palladyne AI Corp. UUUU Energy Fuels Inc. PRME Prime Medicine, Inc. WPC W. P. Carey Inc. IBTA Ibotta, Inc. XGN Exagen Inc. MDAI Spectral AI, Inc. OUST Ouster, Inc. GSHD Goosehead Insurance Denison & NexGen International Perfumes
Example of Deep Discount-- AVD American Vanguard Insider Bought Shares Worth $355,200, According to a Recent SEC Filing Fri, May 17, 2024, 10:32 AM EDT In this article: AVD +3.88% American Vanguard Insider Bought Shares Worth $355,200, According to a Recent SEC Filing
Take a look at a chart of AVD and try not to gasp. That is a waterfall event at the end... a huge red bar down.////
American Vanguard, headquartered in Newport Beach, CA, specializes in developing and marketing products for crop protection, turf and ornamental management, and public and animal health. Its product portfolio includes insecticides, fungicides, herbicides, and more, tailored for a variety of applications. Quarterly Performance Insights For Q1 2024, American Vanguard reported a substantial 35% increase in adjusted EBITDA and an 87% rise in operating income compared to the same period last year. This performance boost is attributed to stringent cost control measures and a transformation program aimed at enhancing operational efficiency, which is projected to add approximately $15 million to annual adjusted EBITDA by 2026. Chairman and CEO Eric Wintemute highlighted the growth across all business segments, including U.S. Crop, U.S. Non-crop, and International markets. Notably, the U.S. Crop segment saw increased sales in granular soil insecticides, herbicides, and cotton and peanut products, benefiting from stable farm economy conditions and favorable weather. The U.S. Non-crop and International segments also recorded sales growth, driven by demand for mosquito adulticides and stronger performance in Mexico and the Asia-Pacific region.
Why the stk is down-- Net Income: Achieved $1.55 million, significantly below the estimated $3.60 million.